Influence of ASPECTS and endovascular thrombectomy in acute ischemic stroke: a meta-analysis.


Journal

Journal of neurointerventional surgery
ISSN: 1759-8486
Titre abrégé: J Neurointerv Surg
Pays: England
ID NLM: 101517079

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 11 07 2018
revised: 16 10 2018
accepted: 18 10 2018
pubmed: 12 11 2018
medline: 20 8 2019
entrez: 12 11 2018
Statut: ppublish

Résumé

Prompt revascularization of the ischemic penumbra following an acute ischemic event (AIS) has established benefit within the literature. However, use of the semi-quantitative Alberta Stroke Program Early CT Score (ASPECTS) to evaluate patient suitability for revascularization has been inconsistent in patient risk stratification and selection. To conduct a meta-analysis to evaluate the available evidence for a clinically valid ASPECTS threshold in assessment of suitability for revascularization following AIS. Two independent reviewers searched Medline (Ovid) and Cochrane Central Register of Systematic Reviews databases for studies appraising outcomes of endovascular thrombectomy (EVT) in relation to a variably-defined preoperative ASPECTS. A total of 13 articles were included. The pooled good outcome proportion after EVT was 41.4% (95% CI 36.4% to 46.6%; p<0.001), with subjective study-specific definitions of favorable and unfavorable subgroup outcomes of 49.7% (95% CI 44.2% to 55.3%; I A subjectively favorable ASPECTS is associated with significantly better outcomes after EVT than an unfavorable ASPECTS, regardless of the cut-off used. EVT is unlikely to be useful in patients with an objectively low ASPECTS and is likely to be useful for those with high ASPECTS; findings in patients with intermediate ASPECTS were equivocal.

Sections du résumé

BACKGROUND BACKGROUND
Prompt revascularization of the ischemic penumbra following an acute ischemic event (AIS) has established benefit within the literature. However, use of the semi-quantitative Alberta Stroke Program Early CT Score (ASPECTS) to evaluate patient suitability for revascularization has been inconsistent in patient risk stratification and selection.
OBJECTIVE OBJECTIVE
To conduct a meta-analysis to evaluate the available evidence for a clinically valid ASPECTS threshold in assessment of suitability for revascularization following AIS.
METHODS METHODS
Two independent reviewers searched Medline (Ovid) and Cochrane Central Register of Systematic Reviews databases for studies appraising outcomes of endovascular thrombectomy (EVT) in relation to a variably-defined preoperative ASPECTS.
RESULTS RESULTS
A total of 13 articles were included. The pooled good outcome proportion after EVT was 41.4% (95% CI 36.4% to 46.6%; p<0.001), with subjective study-specific definitions of favorable and unfavorable subgroup outcomes of 49.7% (95% CI 44.2% to 55.3%; I
CONCLUSIONS CONCLUSIONS
A subjectively favorable ASPECTS is associated with significantly better outcomes after EVT than an unfavorable ASPECTS, regardless of the cut-off used. EVT is unlikely to be useful in patients with an objectively low ASPECTS and is likely to be useful for those with high ASPECTS; findings in patients with intermediate ASPECTS were equivocal.

Identifiants

pubmed: 30415223
pii: neurintsurg-2018-014250
doi: 10.1136/neurintsurg-2018-014250
doi:

Types de publication

Journal Article Meta-Analysis

Langues

eng

Pagination

664-669

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Kevin Phan (K)

NeuroSpine Surgery Research Group (NSURG), Sydney, New South Wales, Australia.

Serag Saleh (S)

NeuroSpine Surgery Research Group (NSURG), Sydney, New South Wales, Australia.

Adam A Dmytriw (AA)

Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada.
Department of Medical Imaging, St Michael's Hospital, Toronto, Ontario, Canada.

Julian Maingard (J)

Interventional Neuroradiology, Austin Health, Heidelberg, Victoria, Australia.

Christen Barras (C)

University of Adelaide, Adelaide, South Australia, Australia.

Joshua A Hirsch (JA)

NeuroEndovascular Program, Massachusetts General Hospital, Boston, Massachusetts, USA.

Hong Kuan Kok (HK)

Department of Radiology, Beaumont Hospital, Dublin, Ireland.

Mark Brooks (M)

Interventional Neuroradiology, Austin Health, Heidelberg, Victoria, Australia.

Ronil V Chandra (RV)

Interventional Neuroradiology Unit, Monash Health, Clayton, Victoria, Australia.
Department of Imaging, Monash University, Clayton, Victoria, Australia.

Hamed Asadi (H)

Department of Radiology, Beaumont Hospital, Dublin, Ireland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH